Vol 8. Issue 1 / January 14, 2008

Scripps Research Discovery Leads to Broad Potential Applications in Biotech Deal - A catalytic antibody discovery has formed the basis of the upcoming acquisition of biotechnology venture CovX by pharmaceutical company Pfizer, Inc.

Scientists Discover Remarkable Editing System For Protein Production - Findings from the Schimmel lab could help identify causes for neurological and other diseases.

Molecular Graphics and Music of the Spheres

Renowned Immunologist Richard Ulevitch Retires as Department Chair

Sarah Tully Wins Damon Runyon Fellowship

Carrie Arnold and Urtzi Garaigorta Awarded Cancer Research Institute/Irvington Institute Fellowships

Team Identifies Human Antibodies that Prevent Hepatitis C Virus Infection in Mouse Model

Scientists Discover Chemical Triggers for Aggression in Mice

New Research Identifies a Novel Receptor and Potential Target to Prevent the Sexual Transmission of HIV-1

Scientists Develop Modeling Method that Increases Our Understanding of Diseases like Cystic Fibrosis and Alzheimer's

Failure is Not an Option

Team Blocks Bacterial Communication System to Prevent Deadly Staph Infections

Scripps Research Wins $51 Million to Study Critical Immune Response Mechanisms

Inventing New Chemistry





Team Finds a Widely Used Anti-Malarial Drug Prevents Cancer Development - A new study offers proof of principle for a novel anti-tumor therapy.